Divi's Laboratories Limited (DIVISLAB) — share transfer

· NSE Neutral
📢 Key Event
Divi's Laboratories submitted SEBI-mandated share transfer certificate for Q1 FY26
💡 Investor Takeaway
This confirms routine compliance with SEBI's shareholding reporting requirements for the quarter.

Divi's Laboratories submitted a SEBI-mandated certificate from its share transfer agent KFin Technologies for the quarter ended June 30, 2026, confirming dematerialization and rematerialization of securities on both NSE and BSE exchanges. The filing details acceptance/rejection status and registrar verification procedures.

📄 View Original Announcement (PDF)

About Divi's Laboratories Limited (DIVISLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,79,470.03 Cr P/E: 72.4 ROE: 16.6% ROCE: 22.1%

View full DIVISLAB stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when DIVISLAB files new disclosures

Track DIVISLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track DIVISLAB — Free

Free account · 2 AI queries/day